This vaccine works by "tricking" the body into thinking it has been exposed to Neisseria meningitidis bacteria, but without actually risking infection. It is usually given as a single injection in the upper arm. Menomune is approved for people over the age of 2, and is currently the only meningococcal vaccine in the United States that is approved for use in people over the age of 55.
This product may not be suitable for everyone. For example, Menomune vials contain dry natural latex rubber, which could cause problems for people with latex allergies. Before getting vaccinated, tell your healthcare provider if you are allergic to latex or have any allergies to foods, dyes, or preservatives. Common side effects include pain or redness at the injection site, fatigue, and a general ill feeling.
(For more information on this vaccine, click Menomune. This article takes an in-depth look at topics such as whether Menomune is available as a generic, when and how to get vaccinated, whether the vaccine contains aluminum, and more.)
Centers for Disease Control and Prevention (CDC). Vaccine information statement: meningococcal vaccines (01/28/08). CDC Web site. Available at: http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed October 5, 2009.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed October 5, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click